Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm Metastasis × Acetaminophen × Clear all

Phase

Status

Sponsor Class

OTHER 1 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 12 Pain, Postoperative 9 Neoplasms 7 Multiple Myeloma 6 Agnosia 6 Cancer Pain 5 Breast Neoplasms 5 Lung Neoplasms 4 Trigger Finger Disorder 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Head and Neck Neoplasms 2 Ganglion Cysts 2 De Quervain Disease 2 Colonic Neoplasms 2 Chronic Pain 2 Acute Pain 2 Vomiting 1 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Strabismus 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Renal Insufficiency 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1

Interventions

Radiosurgery 74 Capecitabine 70 Oxaliplatin 63 Bevacizumab 62 Fluorouracil 61 Gemcitabine 56 Leucovorin 55 Nivolumab 49 pembrolizumab 46 Paclitaxel 41 Irinotecan 41 Radiotherapy 38 Cisplatin 35 Magnetic Resonance Spectroscopy 33 Everolimus 31 Cyclophosphamide 31 Cetuximab 31 Drug Therapy 30 Docetaxel 29 Ipilimumab 28 Carboplatin 27 Trastuzumab 25 Sorafenib 24 Sunitinib 23 Erlotinib Hydrochloride 20 Surveys and Questionnaires 19 Specimen Handling 18 Doxorubicin 18 Biopsy 18 Surgical Procedures, Operative 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00712712 2025-08-29

MEDOR

Institut Bergonié

Phase 2 Completed

78 enrolled 28 charts

Neoplasm Metastasis, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡